ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - misoprostol - טבליה - misoprostol 200 mcg - misoprostol - misoprostol - for the treatment of duodenal and gastric ulcer.treatment and prevention nsaid induced ulcers lesions, erosions, while nsaid therapy continues.use in conjunction with mifepristone subject to the approval of a committee for the termination of pregnancy according to the israeli penal law 1977.first-trimester pregnancy failure: use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. the preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. the preparation can be used for this purpose in an ambulatory setting. the dosage and route of administration will be similar to the use of cytotec in pregnancy termination after using mifegyne. informed consent and medical surveillance are required.softening and dilation of the cervix for performing intraut

ישראל - עברית - Ministry of Health

euromar ltd - tilmicosin as phosphate - תמיסה להזרקה - tilmicosin as phosphate 300 mg / 1 ml

ישראל - עברית - Ministry of Health

merck serono ltd - progesterone - ג'ל - progesterone 8 %w/w - progesterone - progesterone - treatment of infertility due to inadequete luteal phase. for use during in-vitro fertilisation, where infertility is mainly due to tubal idiopathic or endometriosis linked sterility associated with normal obulatory.

ישראל - עברית - Ministry of Health

cts ltd - progesterone micronized - קפסולות - progesterone micronized 200 mg - progesterone - progesterone - vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indication, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy. vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).

ישראל - עברית - Ministry of Health

cts ltd - progesterone - קפסולות - progesterone 100 mg - progesterone - progesterone - vaginal or oral addministration: disorders related to progesterone deficit in particular menopause ( in association with estrogen therapy).vaginal administration: progesterone substitution for ovary deprived women in situation of total progesterone deficiency. supplementation of the luteal phase during in vitro fertilization cycles. supplementation of the luteal phase during spontaneous or induced cycles, in cases of hypofertility or primary or secondary ovarain failure, particulary through dysovulation. in cases of threatning abortion or prevention of repeated abortions due to proven luteal insufficiency. for all other progesterone indications, in the case of : adverse events due to progesterone, contraindication of the oral route of administration hepatopathy.

ישראל - עברית - Ministry of Health

kamada ltd, israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - pregnancy/other obstetric conditions, suppression of rh immunization in non-sensitized rh0 (d) negative women delivering an rh0 positive baby or when the baby's rh type is unknown. suppression of rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. kam rh0 -d im should be given within 72 hours of the event. it may be given even after up to one month although efficacy may be somewhat reduced.transfusion: suppression of rh isoimmunization in rh0 (d) antigen-negative patients transfused with rh0 (d) antigen-positive rbcs of blood components containing rh0 (d) antigen-positive rbcs . initate treatment within 72 hours of exposure.

ישראל - עברית - Ministry of Health

kamada ltd, israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg / 1 ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - suppression of rh immunization in non-sensitized rho(d) negative women delivering an rh positive baby, or when the baby's rh type is unknown. suppression of rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. kam-rho should be given within 72 hours of event. immune thrombocytopenic purpura (itp): rho (d)-positive adults with chronic itp, children with chronic or acute itp, and patients with thrombocytopenia secondary to hiv infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - תמיסה להזרקה - dinoprostone 10 mg/ml - dinoprostone - dinoprostone - therapeutic termination of pregnancy, missed abortion.

ישראל - עברית - Ministry of Health

pharmalogic ltd - oxytocin - תמיסה להזרקה\אינפוזיה - oxytocin 10 iu/ml - oxytocin - induction of labour for medical reasons stimulation of labour in hypotonic uterine inertia during caesarian section following the delivery ot the child prevention and treatment of postpartum uterine atony and haemorrhage.oxytocin injection may also be indicated in early stages of pregnancy as an adjunctive therapy for the management of incomplete inevitable or missed abortion.

ישראל - עברית - Ministry of Health

gramse pharmaceuticals ltd - oxytocin 10 iu/ml - solution for injection - oxytocin - induction of labor for medical reasons. stimulation of labor in hypotonic uterine inertia. during caesarian section following the delivery of the child. prevention and treatment of postpartum uterine atony and haemorrhage. oxytocin may also be indicated in early stages of pregnancy as an adjunctive therapy for the management of incomplete, inevitable or missed abortion.